Axxcess Wealth Management, LLC Amarin Corp Plcuk Transaction History

Axxcess Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.66 - $0.91 $190,410 - $262,535	-288,500 Reduced 22.64%	985,783 $857,000
Q3 2023 Nov 14, 2023	BUY	$0.85 - $1.43 $46,711 - $78,585	54,955 Added 4.51%	1,274,283 $1.17 Million
Q2 2023 Aug 08, 2023	BUY	$1.12 - $1.49 $560,891 - $746,186	500,796 Added 69.7%	1,219,328 $1.45 Million
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $122,315 - $153,180	114,314 Added 18.92%	718,532 $869,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $436,000 - $668,000	-400,000 Reduced 39.83%	604,218 $659,000
Q4 2021 Aug 11, 2022	BUY	$3.24 - $5.18 $3.25 Million - $5.2 Million	1,004,218 New	1,004,218 $2.35 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Axxcess Wealth Management, LLC with notifications on news.